Lymphatic Edema in Congenital Disorders of Glycosylation

Abstract

Congenital disorders of glycosylation (CDG) are a group of metabolic disorders caused by deficient protein glycosylation. PMM2-CDG, the most common CDG, is caused by phosphomannomutase (PMM) deficiency. Clinical symptoms often include neurological involvement in addition to dysmorphic features, failure to thrive, cardiac failure, renal, and endocrine abnormalities. To our knowledge, lymphatic edema in CDG has not been reported. We present two cases of lymphatic edema in PMM2-CDG patients. The first patient was noted to have a larger right leg circumference at two years. Ultrasound investigations did not reveal any obvious vascular or lymphatic malformation. The swelling increased in size over time. At 12 years, lymphoscintigraphy revealed decreased lymphatic draining in both legs, which was more profound in the right leg. The second patient was treated for pulmonary stenosis at age 2 months. Postoperative, the patient suffered from protein-losing enteropathy, hypothyroidism, recurrent bacterial infections, and bilateral lymphatic edema. General condition improved after thyroxin treatment and albumin infusions; however, the bilateral pedal and leg edema remained unresolved. Contrast studies of the lymphatic system showed bilateral hypoplasia distal to the knees. Although both children had secondary factors worsening lymphatic edema in PMM2-CDG, hypoalbuminemia, recurrent infections, cardiac failure, and endocrine abnormalities could not fully explain the clinical features. The additional factors were treated successfully but the therapy did not resolve the lymphatic edema. Based on the abnormal imaging studies of the lymphatic system, we propose that lymphatic vessel hypoplasia is the major cause for lymphatic edema in our patients with PMM2-CDG.

International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up

“…TSH was the most requested biochemical test. In 16%, TSH was above the normal range, in which 29% of those were detected in the newborn screening test while in the remaining, elevated TSH was noticed after the neonatal period …”

“…Levothyroxine therapy was begun in all but was discontinued after few months in some patients presenting with transient hypothyroidism. Hypothyroidism related symptoms including low body temperature, low energy, constipation, and lymphedema have rarely been reported …”

“…Failure to thrive in the first year of life is the most common feature, reported in 66.5%. It is mostly associated with other extra-neurological symptoms 16,21,23,31,51,57,62,65,[69][70][71][72][73][74][75][76][77][78] . Feeding difficulties are frequent in PMM2-CDG (45%).…”

A Case Report of Juvenile Form of Metachromatic Leukodystrophy

“…As already mentioned, this disease occurs due to the deficiency of ARSA enzyme and is an autosomal recessive lysosomal storage disorder (LSD). 4 Our patient was also having severe neurological pain.…”

Vascular ring anomaly in a patient with phosphomannomutase 2 deficiency: A case report and review of the literature

“…Patient demographics, diagnoses, and symptoms are presented in Tables 1 and 2. From 960 patients described in the literature, 14 had reported CHD 10‐19 . The most common form of CHD in the patients of our literature review was tetralogy of Fallot (TOF) (5/14 patients, 35.7%), followed by persistent ductus arteriosus (PDA) (3/14, 21.4%) and truncus arteriosus (3/14, 21.4%).…”